Johnson & Johnson Blog | Talkmarkets

Latest Posts

DOW + (8 S&P 500 Top Weights) Earnings Estimates And Revisions

Article By: T.J. Hayes

Sunday, January 12, 2020 9:43 PM EST

The cumulative 2020 earnings power of these 38 stocks was revised down by -1.97% in the past 60 days [A significant portion of this downward revision is related to BA (short term markdown in EPS) – which will fully recover its earnings power 2021].

In this article: ATVXRVZSCOCATVXRVZSCO, ABT, AXP, BA, BAC, C, CAT, CVX, DIS, DOW, GS, HD, IBM, JNJ, JPM, KO, MA, MCD, MMM, MRK, NKE, PEP, PFE, PG, T, TRV, UNH, UTX, V, VZ, WFC, WMT, XOM, AAPL, CSCO, INTC, MSFT, WBA, DIA, SPY

Read

3 Dividend-Paying Large Cap Pharma Stocks To Consider For 2020

Article By: Zacks Investment Research

Friday, December 27, 2019 5:37 PM EST

The strong end to the year has helped lift the S&P 500 over 28% in 2019. But investors now wonder what might be in store for equities in the upcoming year.

In this article: JNJ, MRK, ABBV Also: ABT, AGN, AMZN

Read

JNJ Bullish Outlook Suggests Further Upside For Next Year

Article By: Elliottwave Forecast

Friday, December 27, 2019 12:02 PM EST

JNJ saw a sideways consolidation in the recent 2 years within a Bullish Triangle and the stock is currently in the process of breaking out of that range.

In this article: JNJ

Read